Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances

Join us for a panel exploration of biotech licensing and economic arrangements, including upfront license fees, technology access payments, milestone triggers, commercial due diligence fees, clinical trial milestones, royalty rates and structures, and royalty offset gambits.